Results 111 to 120 of about 1,818 (165)

An efficient molecular genetic testing strategy for incontinentia pigmenti based on single-tube long fragment read sequencing. [PDF]

NPJ Genom Med
Chen M, Tan MH, Liu J, Yang YM, Yu JL, He LJ, Huang YZ, Sun YX, Qian YQ, Yan K, Dong MY.   +10 more
europepmc   +1 more source

Non-Skewed X-inactivation Results in NF-κB Essential Modulator (NEMO) Δ-exon 5-autoinflammatory Syndrome (NEMO-NDAS) in a Female with Incontinentia Pigmenti. [PDF]

J Clin Immunol
Eigemann J, Janda A, Schuetz C, Lee-Kirsch MA, Schulz A, Hoenig M, Furlan I, Jacobsen EM, Zinngrebe J, Peters S, Drewes C, Siebert R, Rump EM, Führer M, Lorenz M, Pannicke U, Kölsch U, Debatin KM, von Bernuth H, Schwarz K, Felgentreff K.   +20 more
europepmc   +1 more source

Incontinentia pigmenti.

Indian pediatrics, 2007
openaire   +1 more source

Incontinentia pigmenti.

Indian journal of dermatology, venereology and leprology, 2012
openaire   +1 more source

Incontinentia pigmenti

Sonda : List studenata Stomatološkog fakulteta Sveučilišta u Zagrebu, 2003
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Incontinentia pigmenti

Archives de Pédiatrie, 1996
Incontinentia pigmenti (IP) is a hereditary syndrome characterized by specific skin lesions occurring mostly during the neonatal period (96% of the cases before 6 weeks of age). These skin lesions have four steps of evolution: inflammatory or erythemato-bullous stage (very often associated with peripheral blood hyper-eosinophilia), proliferative or ...
B P, Le Roux, G, Hornez, P, Beaulieu, H, Darie, P, Millet   +4 more
  +10 more sources

Incontinentia pigmenti

Seminars in Cutaneous Medicine and Surgery, 1997
This article reviews the clinical features, histopathology, genetics, and differential diagnosis of incontinentia pigmenti. Emphasis is placed on appropriate management strategies for patients with incontinentia pigmenti.
J S, Francis, V P, Sybert
openaire   +2 more sources